Perspectiva global sobre los datos de tratamientos emergentes con inhibidores de TQB para LLC y LCM en recidiva/refractarios en 2022

Content Format:

Text Module

Credit Type:

--

Credits:

--
Uma perspectiva global sobre os dados emergentes da terapia com inibidor de BTK para LLC e LCM recidivantes/refratários em 2022

Content Format:

Text Module

Credit Type:

--

Credits:

--
Une perspective globale sur les données émergentes relatives à la thérapie par inhibiteurs BTK chez les patients atteints de LLC ou du LCM récidivant/réfractaire en 2022

Content Format:

Text Module

Credit Type:

--

Credits:

--
A Global Perspective on Emerging BTK Inhibitor Therapy Data for Relapsed/Refractory CLL and MCL in 2022

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
A Global Perspective on Emerging BTK Inhibitor Therapy Data for CLL and MCL in 2022

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Nouvelles données sur les inhibiteurs de BTK pour la LLC et le LCM : Des experts discutent de l’EHA 2022

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Neue Daten zu BTK-Inhibitoren für CLL und MCL: Expertendiskussion EHA 2022

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Nuovi dati sugli inibitori di BTK nella CLL e MCL: gli esperti discutono lEHA 2022

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Novos dados sobre os inibidores de BTK para LLC e LCM: especialistas discutem o EHA 2022

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Nuevos datos sobre inhibidores de QBT para la LLC y el LCM: expertos hablan sobre la EHA 2022

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
New Evidence With BTK Inhibitor Therapy in CLL and MCL From EHA 2022

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
New Data on BTK Inhibitors for CLL and MCL: Experts Discuss EHA 2022

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
COVID-19 Vaccination in Patients With CLL: Where Do We Stand?

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Key Data From EHA 2021: A European Expert Perspective

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
B-Cell Lymphomas: A European Perspective on Key Trials From ASH 2020

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
A European Perspective on Key Findings in CLL and Lymphomas From ASH 2020

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
My Thoughts on the Implications of Key New Data in B-Cell Malignancies From ASCO and EHA 2020

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Application of New Data in B-Cell Malignancies From ASCO and EHA 2020

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
A European Perspective on Key Findings in CLL and Lymphomas From ASH 2019

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--